Other
2
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Tisento TherapeuticsMA - Cambridge
2 programs2
IW-6463Phase 11 trial
IW-6463Phase 11 trial
Active Trials
Temple TherapeuticsNetherlands - Geleen
1 programIncreasing Inclusionary Practices in Faith CommunitiesN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Tisento TherapeuticsIW-6463
Tisento TherapeuticsIW-6463
Temple TherapeuticsIncreasing Inclusionary Practices in Faith Communities
Clinical Trials (3)
Total enrollment: 834 patients across 3 trials
IW-6463 Safety Study in Healthy Elderly Subjects
Start: Jan 2020Est. completion: May 202024 patients
Phase 1Terminated
A Study of IW-6463 in Healthy Volunteers
Start: Feb 2019Est. completion: Oct 2019110 patients
Phase 1Completed
Creating Welcoming Faith Communities for People With Serious Mental Illnesses
Start: Jan 2024Est. completion: Dec 2025700 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 834 patients
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.